Cowen Investment Management’s Cardio Diagnostics CDIO Stock Holding History
Bought
Maintained
Sold
Other funds holding CDIO
LA
PAMP
YCM
CCM
ASM
BFM
CSC
Cowen Investment Management's CDIO Position: Q4 2022 in Review
Cowen Investment Management sold out of Cardio Diagnostics (CDIO) in Q4 2022, closing a stake of 1,667 shares — an estimated $502K sold.
Cowen Investment Management first reported a position in CDIO in Q1 2022 and held it in 3 quarters. The position peaked at $502K in Q3 2022. 11 funds tracked by Wall St. Rank hold CDIO as of Q4 2022.
- Cowen Investment Management reported no remaining Cardio Diagnostics position as of Q4 2022 after selling out during the quarter.
- Cowen Investment Management sold 1,667 Cardio Diagnostics shares in Q4 2022, an estimated $502K.
- Cowen Investment Management first reported a position in Cardio Diagnostics in Q1 2022 and held it in 3 quarters.
- Cowen Investment Management's Cardio Diagnostics position peaked at $502K in Q3 2022.
- 11 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q4 2022.
Based on Cowen Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.